Hepatitis B virus infection
C Trépo, HLY Chan, A Lok - The Lancet, 2014 - thelancet.com
Hepatitis B virus infection is a major public health problem worldwide; roughly 30% of the
world's population show serological evidence of current or past infection. Hepatitis B virus is …
world's population show serological evidence of current or past infection. Hepatitis B virus is …
The role of quantitative hepatitis B surface antigen revisited
In the past 10 years, there has been a lot of enthusiasm surrounding the use of serum
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Chronic hepatitis B virus (HBV) infection is a major health concern worldwide, frequently
leading to liver cirrhosis, liver failure, and hepatocellular carcinoma. Evidence suggests that …
leading to liver cirrhosis, liver failure, and hepatocellular carcinoma. Evidence suggests that …
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
YF Liaw, JH Kao, T Piratvisuth, HLY Chan… - Hepatology …, 2012 - Springer
Large volume of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2008. These include further studies in …
(HBV) infection have become available since 2008. These include further studies in …
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
BACKGROUND & AIMS: Patients with chronic hepatitis B virus (HBV) infection have a high
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
Hepatitis B virus: advances in prevention, diagnosis, and therapy
Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …
Hepatitis B virus–specific and global T-cell dysfunction in chronic hepatitis B
Background & Aims T cells play a critical role in viral infection. We examined whether T-cell
effector and regulatory responses can define clinical stages of chronic hepatitis B (CHB) …
effector and regulatory responses can define clinical stages of chronic hepatitis B (CHB) …
Prediction models of long‐term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles
Integrating host and HBV characteristics, this study aimed to develop models for predicting
long‐term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus …
long‐term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus …
[HTML][HTML] Hepatitis B surface antigen quantification: why and how to use it in 2011–a core group report
HLY Chan, A Thompson, M Martinot-Peignoux… - Journal of …, 2011 - Elsevier
Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays
were cumbersome. The recent availability of commercial quantitative assays has restarted …
were cumbersome. The recent availability of commercial quantitative assays has restarted …
[HTML][HTML] KASL clinical practice guidelines: management of hepatitis C
Korean Association for the Study of the … - Clinical and …, 2016 - ncbi.nlm.nih.gov
Aims The Korean Association for the Study of the Liver (KASL) Practice Guidelines for
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …